Search

Displaying results 3811 - 3820 of 7479 in total
  1. Drug

    Recombinant Bacterial ACE2 Receptors-like Enzyme

    go.drugbank.com/drugs/DB15741
    Investigational

    ._ The molecule, an Angiotensin Converting Enzyme 2 (ACE2)-like enzyme, shares structural similarities to the mammalian ACE2. B38-CAP is an ACE2-like enzyme which decreases angiotensin II levels.

  2. Drug

    TC-2216

    go.drugbank.com/drugs/DB06044
    Investigational

    TC-2216 is an investigational novel small molecule that is being developed as an oral treatment for depression and anxiety disorders.

  3. Drug

    Laquinimod

    go.drugbank.com/drugs/DB06685
    Investigational

    Laquinimod is an immunomodulator developed by Active Biotech and produced by Teva Pharmaceutical Industries. … It is currently under development in phase III trials for treatment of multiple sclerosis as an oral therapy, like fingolimod.

  4. Drug

    Tangerine peel

    go.drugbank.com/drugs/DB14316
    Investigational

    It is not an approved drug.

  5. Drug

    Coconut oil

    go.drugbank.com/drugs/DB14322
    Investigational

    It is not an approved drug.

  6. Drug

    Sunflower oil

    go.drugbank.com/drugs/DB14329
    Investigational

    It is not an approved drug.

  7. Drug

    Bergamot oil

    go.drugbank.com/drugs/DB14335
    Investigational

    It is not an approved drug.

  8. Drug

    Chondrus crispus

    go.drugbank.com/drugs/DB14367
    Investigational

    It is not an approved drug.

  9. Drug

    HMI-103

    go.drugbank.com/drugs/DB17684
    Investigational

    HMI-102 is an investigational gene therapy designed to encode the phenylalanine-4-hydroxylase (PAH) gene, mutated in people with phenylketonuria.

  10. Drug

    AMB-301

    go.drugbank.com/drugs/DB18094
    Experimental

    AMB-301 is an AAV gene therapy delivering E-selectin.[L48101] It is under investigation for the treatment of Buerger disease.